Yelin Lapidot Holdings Management Ltd. Syndax Pharmaceuticals Inc Transaction History
Yelin Lapidot Holdings Management Ltd.
- $486 Billion
- Q1 2024
A detailed history of Yelin Lapidot Holdings Management Ltd. transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Yelin Lapidot Holdings Management Ltd. holds 114,530 shares of SNDX stock, worth $2.4 Million. This represents 0.56% of its overall portfolio holdings.
Number of Shares
114,530
Previous 114,530
-0.0%
Holding current value
$2.4 Million
Previous $2.47 Billion
10.13%
% of portfolio
0.56%
Previous 0.6%
Shares
1 transactions
Others Institutions Holding SNDX
# of Institutions
195Shares Held
90MCall Options Held
353KPut Options Held
207K-
Black Rock Inc. New York, NY7.55MShares$158 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA7.44MShares$156 Million0.03% of portfolio
-
Kynam Capital Management, LP Princeton, NJ5.66MShares$118 Million14.14% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.93MShares$103 Million0.0% of portfolio
-
State Street Corp Boston, MA4.82MShares$101 Million0.01% of portfolio
About Syndax Pharmaceuticals Inc
- Ticker SNDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,565,200
- Market Cap $1.18B
- Description
- Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...